Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

ACTRIMS Forum 2026 - Abstract Sessions and Invited Sessions

Multiple Sclerosis Journal

Impact Factor: 4.1 / 5-Year Impact Factor: 4.9

Journal Homepage Submission guidelines

Restricted access

Abstract

First published online May, 2026

ACTRIMS Forum 2026 - Abstract Sessions and Invited Sessions

Volume 32, Issue 2_suppl

https://doi.org/10.1177/13524585261433070

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

ECTRIMS 2015 Committees

Retricted access

Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: No

Retricted access

Interferon beta treatment in multiple sclerosis: the European clinical trials

Retricted access

A New Synthetic Protease Inhibitor,E-3123,Prevents Lysosomal and Mitochondrial Fragility in Rat Caerulein-Induced Pancreatitis